Erkki Ruoslahti
Director, Ocata Therapeutics, Inc.
Companies
- Caladrius BiosciencesBoard member Sep 16, 2022 to Jan 11, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Caladrius Biosciences LSTA1,191,144 shares2$1.2M at $0.98Jan 11, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 9, 2023Granted 20,000 shares of Caladrius Biosciences2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCaladrius Biosciences, Board member
- 2